Dengpeng Ren

发表

Inhibition of PLK4 might enhance the anti‐tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway

Rui Cheng, Yan Sun, Chao Xu, 2020, Journal of cellular and molecular medicine.